Stony Brook University Hospital
Stony Brook, New York, 11794, United States
NCT Number: NCT00552695
This study will determine whether application of a patch containing a topical anesthetic (numbing medicine) named lidocaine can reduce the pain of subsequent insertion of an intravenous catheter in Emergency Department patients.
Looking for future studies?
Notify Me3 year and older
All sexes
Interventional
Phase 2
Stony Brook, New York, 11794, United States
Patients will be randomly assigned to an active lidocaine patch or a patch that conatins a placebo or inactive agent. Neither the patient nor the practitioner will know which patch is used since they will appear identical.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lidocaine 70 mg/tetracaine 70 mg
Other names: Synera
Placebo patch identical in appearance to Synera
Time frame: 0 MINUTES
Pain on 100 mm Visual Aanalog Scale from 0 (no pain) to 100 (most pain).
Time frame: After first attempt of catheter insertion
Percentage of patients in whom intravenous catheter was inserted successfully
Stony Brook University
Other
Phase II Study of Lidoderm Patches Prior to Intravenous Catheter Insertion.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07728162
Diabetes Mellitus, Disease Attributes
Bolu, Turkey (Türkiye)
View Trial DetailsNCT04290741
Disease Attributes, Emergencies
Durham, North Carolina, United States
View Trial DetailsNCT06598410
Anxiety, Anxiety Disorders
Mersin, Turkey (Türkiye)
View Trial DetailsNCT05434169
Disease Attributes, Effect of Positive Therapeutic Communication on Pain
Fribourg, Switzerland
View Trial Details